Entities / Company
Hanmi Pharmaceutical.
South Korean pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Hanmi Pharmaceutical won approval for its homegrown GLP-1 obesity drug, while Eli Lilly expands its market presence.Some support1 report
-
A consortium involving Samsung SDS, Hanmi Pharmaceutical, and Air Studio received support for an AI project via a voucher program.Some support1 report
-
FDA granted Orphan Drug Designation to BAL0891, a therapeutic targeting the TTK protein, developed by Hanmi Pharmaceutical.Some support1 report
-
Hanmi Pharmaceutical, a South Korean company, successfully licensed one of its obesity drug candidates to the multinational giant Hoffmann-La Roche on August 1, 2026.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Hanmi Pharmaceutical this week
News at the entities that move Hanmi Pharmaceutical most-
Hoffmann-La Roche StructuralOmar Khwaja, a Fellow of the Royal College of Physicians, leads clinical research at Cancer Research UK.Moves Hanmi Pharmaceutical
Connections
The 4 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Hoffmann-La Roche Structural
Hanmi Pharmaceutical holds a licensing agreement with Roche Group for its obesity drug.
-
National IT Industry Promotion Agency Structural
The government agency provides structured financial and operational support to the company via a voucher program.
-
Air Studio Structural
Hanmi Pharmaceutical utilizes Air Studio to conduct Quality Assurance operations.
-
Samsung SDS Operational
Hanmi Pharmaceutical and Samsung SDS are consortium partners collaborating on an AI project.